InMed Pharmaceuticals (INM) FCF Margin Growth (1y) (2022 - 2025)
InMed Pharmaceuticals (INM) FCF Margin Growth (1y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 74.00 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -1,043.00 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -573.00 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 734.00 |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 301.00 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -45,890.00 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 407.00 |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 610.00 |
| 10 | InMed Pharmaceuticals | 6.04 Mn | 796,124.14 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -6,465.00 |
| Sep 30, 2025 | 93.00 |
| Jun 30, 2025 | -5,610.00 |
| Mar 31, 2025 | 3,342.00 |
| Dec 31, 2024 | -7,605.00 |
| Sep 30, 2024 | 9,663.00 |
| Jun 30, 2024 | -5,037.00 |
| Mar 31, 2024 | -473.00 |
| Dec 31, 2023 | 42,850.00 |
| Sep 30, 2023 | 46,205.00 |
| Jun 30, 2023 | 75,640.00 |
| Mar 31, 2023 | 156,865.00 |
| Dec 31, 2022 | 67,463.00 |